Grey and white matter differences in brain energy metabolism in first episode schizophrenia: 31P-MRS chemical shift imaging at 4 Tesla

Psychiatry Research - Neuroimaging

Volumn 146, Issue 2, 2006, Pages 127-135

  Jensen, J Eric ^d,e   Miller, Jodi ^a,c   Williamson, Peter C ^a   Neufeld, Richard W J ^a   Menon, Ravi S ^a,b   Malla, Ashok ^f   Manchanda, Rahul ^a   Schaefer, Betsy ^a   Densmore, Maria ^c   Drost, Dick J ^a,c  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b ROBARTS RESEARCH INSTITUTE   (Canada)

^c ST JOSEPH S HEALTH CENTRE   (Canada)

^d MCLEAN HOSPITAL   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE   (Canada)

Author keywords

Brain; Chemical shift imaging; Energy metabolism; Magnetic resonance spectroscopy; Phospholipids; Schizophrenia

Indexed keywords

ADENOSINE TRIPHOSPHATE; BRAIN PROTEIN;

ADULT; ARTICLE; BRAIN METABOLISM; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC IMAGING; ENERGY METABOLISM; FEMALE; FRONTAL CORTEX; FRONTAL LOBE; GRAY MATTER; HUMAN; HUMAN TISSUE; MALE; METABOLITE; NEUROIMAGING; PHOSPHATE METABOLISM; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; REGRESSION ANALYSIS; SCHIZOPHRENIA; STRIATE CORTEX; TEMPORAL CORTEX; TISSUE SPECIFICITY; WHITE MATTER;

ADULT; BRAIN; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; FRONTAL LOBE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PHOSPHORUS; REGRESSION ANALYSIS; SCHIZOPHRENIA; TIME FACTORS;

EID: 33645874180     PISSN: 09254927     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pscychresns.2005.11.004     Document Type: Article

References (28)

1. Andreasen N.C. Scale for the Assessment of Negative Symptoms (1984), University of Iowa, Iowa City, IA
2. Andreasen N.C. Scale for the Assessment of Positive Symptoms (1984), University of Iowa, Iowa City, IA
3. Benes M.F. Model generation and testing to probe neural circuitry in the cingulate cortex of post-mortem schizophrenic brain. Schizophrenia Bulletin 24 (1998) 219-230
4. Brown T.R., Kincaid B.M., and Ugurbil K. NMR chemical shift imaging in three dimensions. Proceedings of the National Academy of Sciences of the United States of America 79 (1982) 3523-3526
5. Buchsbaum M.S., Tang C.Y., Peled S., Gudbjartsson H., Lu D., Hazlett E.A., Downhill J., Haznedar M., Fallon J.H., and Atlas S.W. MRI white matter diffusion anisotropy and PET metabolic rate in schizophrenia. Neuroreport 9 (1998) 425-430
6. Dager S.R., Friedman S.D., Parow A., Demopulos C., Stoll A., Lyoo I.K., Dunner D.L., and Renshaw P.F. Brain metabolic alterations in medication-free patients with bipolar disorder. Archives of General Psychiatry 61 5 (2004) 450-458
7. First M.B., Spitzer R.L., Gibbon M., et al. Structured Clinical Interview (SCID) for DSM-IV Axis 1 Disorders (1997), American Psychiatric Press Inc., Washington, DC
8. Gangadhar B.N., Jayakumar P.N., Subbakrishna D.K., Janakiramaiah N., and Keshavan M.S. Basal ganglia high-energy phosphate metabolism in neuroleptic-naïve patients with schizophrenia: a 31-phosphorus magnetic resonance spectroscopic study. American Journal of Psychiatry 161 (2004) 1304-1306
9. 31P spectroscopic imaging of human brain at 4 Tesla: assessment of gray and white matter differences of phosphocreatine and ATP. Magnetic Resonance in Medicine 45 (2001) 46-52
10. Hinsberger A.D., Williamson P.C., Carr T.J., Stanley J.A., Drost D.J., Densmore M., MacFabe G.C., and Montemurro D.G. Magnetic resonance imaging volumetric and phosphorus-31 magnetic resonance spectroscopy measurements in schizophrenia. Journal of Psychiatry and Neuroscience 22 2 (1997) 111-117
11. 31P chemical-shift imaging study at 4.0 Tesla. British Journal of Psychiatry 180 (2002) 39-44
12. 31P-MRS: measuring the phospholipid resonances at 4 Tesla from small voxels. NMR in Biomedicine 15 (2002) 338-347
13. Jensen J.E., Miller J., Williamson P.C., Neufeld W.J., Menon R.S., Malla A., Manchanda R., Schaefer B., Densmore M., and Drost D.J. Focal changes in brain energy phospholipid metabolism in first-episode schizophrenia. British Journal of Psychiatry 184 (2004) 409-415
14. Jones E.G. Cortical development and thalamic pathology in schizophrenia. Schizophrenia Bulletin 23 (1997) 483-501
15. Keshavan M.S., Stanley J.A., and Pettegrew J.W. Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings: Part II. Biological Psychiatry 48 (2000) 369-380
16. Kong J., Shepel P.N., Holden C.P., Mackiewicz M., Pack A.I., and Geiger J.D. Brain glycogen decreases with increased periods of wakefulness: implications for homeostatic drive to sleep. Journal of Neuroscience 22 13 (2002) 5581-5587
17. Lipska B.K., and Weinberger D.R. Delayed effects of neonatal hippocampal damage on haloperidol-induced catalepsy and apomorphine-induced sterotypic behaviors in the rat. Developmental Brain Research 75 (1993) 213-222
18. Lim K.O., Adalsteinsson E., Spielmen D., Sullivan E.V., Rosenbloom M.J., and Pfefferbaum A. Proton magnetic resonance spectroscopic imaging of cortical gray and white matter in schizophrenia. Archives if General Psychiatry 55 (1998) 346-352
19. 31P metabolite differences in human cerebral gray and white matter. Magnetic Resonance in Medicine 39 3 (1998) 346-353
20. Paradiso S., Andreasen N.C., Crespo-Facorro B., O'Leary D.S., Watkins G.L., Ponto-Boles L.L., and Hichwa R.D. Emotions in unmedicated patients with schizophrenia during evaluation with positron emission tomography. American Journal of Psychiatry 160 (2003) 1775-1783
21. 31P chemical shift imaging study of medicated schizophrenic patients and healthy controls. Biological Psychiatry 45 (1999) 687-693
22. 31P NMR spectroscopy shows an increase in glycerophosphorylcholine concentration without alterations in mitochondrial function in the prefrontal cortex of medicated schizophrenic patients at rest. European Journal of Neuroscience 20 (2004) 749-756
23. Soyka M., Koch W., Möller H.J., Ruther T., and Tatsch K. Hypermetabolic pattern in frontal cortex and other brain regions in unmedicated schizophrenia patients. Results from a FDG-PET study. European Archives of Psychiatry and Clinical Neuroscience 255 5 (2005) 308-312
24. Swanson R.A., Sagar S.M., and Sharp F.R. Regional brain glygogen stores and metabolism during complete global ischaemia. Neurological Research 11 (1989) 24-28
25. Théberge J., Bartha R., Drost D.J., Menon R.S., Malla A., Takhar J., Neufeld R.W., Rogers J., Pavlosky W., Schaefer B., Densmore M., AlSemaan Y., and Williamson P.C. Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers. American Journal of Psychiatry 159 11 (2002) 1944-1946
26. 31P-magneto-resonance spectroscopic study. Psychiatry Research: Neuroimaging 76 (1997) 123-129
27. 31P magnetic resonance spectroscopy. Phospholipid Spectrum Disorder in Psychiatry and Neurology. 2nd edition (2003), Marius Press, Carnforth, Lancashire, UK 221-238
28. 31P-spectroscopy of frontal lobe in schizophrenia: alterations in phospholipid and high-energy phosphate metabolism. Schizophrenia Research 58 2-3 (2002) 117-122